Clinical Trial Update: Glucarpidase After High-Dose Methotrexate in Patients With Osteosarcoma [EARLY_Phase 1]

View source ↗

Summary

This document provides an update on a Phase 1 trial evaluating glucarpidase after high-dose methotrexate in osteosarcoma patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteosarcoma

Drugs mentioned

• Glucarpidase (glucarpidase)

Snippet

Sponsor: OHSU Knight Cancer Institute | Conditions: Osteosarcoma | EARLY_Phase 1 | Status: ACTIVE_NOT_RECRUITING